HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Arnon Nagler Selected Research

Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)

12/2022Should anti-thymocyte globulin be added in post-transplant cyclophosphamide based matched unrelated donor peripheral blood stem cell transplantation for acute myeloid leukemia? A study on behalf of the Acute Leukemia Working Party of the EBMT.
10/2022Comparison of Outcomes after Unrelated Double-Unit Cord Blood and Haploidentical Peripheral Blood Stem Cell Transplantation in Adults with Acute Myelogenous Leukemia: A Study on Behalf of Eurocord and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
1/2021Comparison of Haploidentical Bone Marrow versus Matched Unrelated Donor Peripheral Blood Stem Cell Transplantation with Posttransplant Cyclophosphamide in Patients with Acute Leukemia.
1/2019Impact of anti-thymocyte globulin on results of allogeneic peripheral blood stem cell transplantation for patients with Philadelphia-positive acute lymphoblastic leukaemia: An analysis by the Acute Leukemia Working Party of the EBMT.
1/2018Anti-thymocyte globulin improves survival free from relapse and graft-versus-host disease after allogeneic peripheral blood stem cell transplantation in patients with Philadelphia-negative acute lymphoblastic leukemia: An analysis by the Acute Leukemia Working Party of the EBMT.
1/2017Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
5/2016High CD3+ and CD34+ peripheral blood stem cell grafts content is associated with increased risk of graft-versus-host disease without beneficial effect on disease control after reduced-intensity conditioning allogeneic transplantation from matched unrelated donors for acute myeloid leukemia - an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
1/2016Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.
4/2004Platelets but not monocytes contribute to the plasma levels of factor XIII subunit A in patients undergoing autologous peripheral blood stem cell transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Arnon Nagler Research Topics

Disease

224Leukemia
05/2024 - 01/2002
192Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2024 - 01/2002
98Graft vs Host Disease (Graft-Versus-Host Disease)
05/2024 - 12/2002
98Neoplasms (Cancer)
01/2024 - 01/2002
71Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
03/2024 - 01/2002
59Multiple Myeloma
05/2023 - 12/2002
36Hematologic Neoplasms (Hematological Malignancy)
12/2023 - 03/2002
27Lymphoma (Lymphomas)
01/2024 - 08/2003
24BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2022 - 01/2002
22Infections
04/2024 - 12/2002
21Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2023 - 12/2007
18Pathologic Complete Response
05/2024 - 10/2004
17B-Cell Lymphoma (Lymphoma, B Cell)
01/2023 - 11/2007
17Bronchiolitis Obliterans Syndrome
11/2021 - 08/2002
13Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2022 - 01/2002
10Neoplasm Metastasis (Metastasis)
10/2018 - 12/2002
9Chromosome Aberrations (Chromosome Abnormalities)
01/2024 - 10/2007
9Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2023 - 01/2008
9Philadelphia Chromosome
01/2021 - 04/2006
9Fibrosis (Cirrhosis)
01/2013 - 07/2003
8Hodgkin Disease (Hodgkin's Disease)
12/2023 - 06/2003
8Disease Progression
12/2022 - 03/2007
8Residual Neoplasm
12/2020 - 01/2004
7Primary Myelofibrosis (Myelosclerosis)
11/2021 - 12/2009
7Inflammation (Inflammations)
01/2021 - 08/2009
7Melanoma (Melanoma, Malignant)
01/2020 - 03/2006
6Hematologic Diseases (Blood Diseases)
01/2021 - 01/2013
6Thrombocytopenia (Thrombopenia)
07/2020 - 06/2010
6Blast Crisis (Blast Phase)
10/2019 - 01/2002
6Neutropenia
10/2019 - 08/2003
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2019 - 01/2012
4Communicable Diseases (Infectious Diseases)
04/2024 - 01/2016
4B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2019 - 01/2002

Drug/Important Bio-Agent (IBA)

68Cyclophosphamide (Cytoxan)FDA LinkGeneric
05/2024 - 10/2013
36fludarabineIBA
12/2023 - 12/2002
32Busulfan (Busulfex)FDA Link
10/2023 - 01/2003
29Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA
05/2024 - 12/2002
22Chimeric Antigen ReceptorsIBA
12/2023 - 09/2014
19halofuginoneIBA
06/2015 - 05/2002
14Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
12/2023 - 01/2016
14treosulfanIBA
10/2023 - 12/2007
14Bortezomib (Velcade)FDA Link
12/2020 - 04/2006
12Melphalan (Alkeran)FDA LinkGeneric
12/2023 - 12/2002
12Proteins (Proteins, Gene)FDA Link
05/2023 - 01/2002
12heparanaseIBA
01/2023 - 01/2002
11Cyclosporine (Ciclosporin)FDA LinkGeneric
04/2024 - 01/2003
11Tyrosine Kinase InhibitorsIBA
01/2022 - 06/2010
11Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2021 - 01/2004
11Imatinib Mesylate (Gleevec)FDA Link
05/2014 - 10/2004
10Methotrexate (Mexate)FDA LinkGeneric
04/2024 - 01/2003
10AntigensIBA
04/2024 - 03/2003
10AntibodiesIBA
01/2020 - 05/2002
10CollagenIBA
11/2012 - 05/2002
9LigandsIBA
01/2019 - 06/2005
8Mycophenolic Acid (Cellcept)FDA LinkGeneric
04/2024 - 03/2016
8HLA Antigens (Human Leukocyte Antigens)IBA
11/2022 - 11/2008
6SteroidsIBA
01/2024 - 12/2002
6CytokinesIBA
10/2023 - 04/2010
6tisagenlecleucelIBA
12/2022 - 01/2019
6Rituximab (Mabthera)FDA Link
01/2018 - 08/2003
6Azacitidine (5 Azacytidine)FDA Link
04/2017 - 05/2010
6Collagen Type I (Type I Collagen)IBA
02/2007 - 07/2003
5Calcineurin InhibitorsIBA
04/2024 - 03/2016
5Immunoglobulins (Immunoglobulin)IBA
12/2023 - 07/2009
5Interleukin-15 (Interleukin 15)IBA
10/2023 - 08/2003
5Lenalidomide (CC 5013)FDA Link
01/2021 - 04/2008
5Dexamethasone (Maxidex)FDA LinkGeneric
12/2020 - 01/2012
5GlobulinsIBA
02/2020 - 01/2003
5Monoclonal AntibodiesIBA
01/2019 - 01/2003
51-dodecylpyridoxal (PLD)IBA
07/2016 - 09/2007
5liposomal doxorubicin (Doxil)FDA Link
07/2016 - 09/2007
5BKT140IBA
05/2014 - 03/2011
4IronIBA
12/2023 - 07/2014
4Thomsen-Friedenreich antibodiesIBA
02/2020 - 01/2003
4Sorafenib (BAY 43-9006)FDA Link
03/2019 - 01/2018
4RNA (Ribonucleic Acid)IBA
01/2019 - 01/2002
4EnzymesIBA
10/2018 - 09/2008
4AlkaloidsIBA
06/2015 - 01/2011
4Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
06/2015 - 09/2004
4Thalidomide (Thalomid)FDA Link
09/2014 - 11/2004
4Interleukin-2 (IL2)IBA
09/2013 - 05/2009
4Transforming Growth Factor beta (TGF-beta)IBA
01/2011 - 09/2008
4Interleukin-12 (IL 12)IBA
09/2004 - 03/2003
3Tacrolimus (Prograf)FDA LinkGeneric
04/2024 - 10/2020

Therapy/Procedure

219Transplantation
05/2024 - 08/2002
165Stem Cell Transplantation
05/2024 - 01/2002
99Hematopoietic Stem Cell Transplantation
04/2024 - 01/2002
96Therapeutics
01/2024 - 03/2002
84Cell Transplantation
04/2024 - 02/2013
48Drug Therapy (Chemotherapy)
03/2024 - 01/2002
27Immunotherapy
12/2023 - 01/2002
23Haploidentical Transplantation
05/2024 - 04/2015
22Bone Marrow Transplantation (Transplantation, Bone Marrow)
01/2022 - 08/2002
21Homologous Transplantation
04/2024 - 01/2002
9Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
12/2022 - 04/2004
7Salvage Therapy
07/2023 - 03/2008
6Autologous Transplantation
01/2023 - 01/2010
5Cell- and Tissue-Based Therapy (Cell Therapy)
01/2013 - 03/2006
4Hematopoietic Stem Cell Mobilization
09/2021 - 01/2014
4Radiotherapy
01/2018 - 05/2005